NFS1 and colorectal carcinoma: In conclusion, our study indicates that NFS1 is a promising prognostic indicator and that the inhibition of NFS1 through the development of targeted inhibitors may be a potential therapeutic strategy for improving the antitumor efficacy of platinum-based chemotherapy in CRC treatment.